4th Quarter - Amendment
DALRYMPLE & ASSOCIATES, LLC for SANOFI PASTEUR
Client
Income
$46,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 12, 2016 | $46,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jan 14, 2016 | $46,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Coverage and Reimbursement for Administration of Vaccines and Immunization
Foreign entity interest: Sanofi SA
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | — |
Homeland Security HOM
CDC Strategic National Stockpile Appropriations for Smallpox Vaccine Procurement
Foreign entity interest: Sanofi SA
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | — |
Medical/Disease Research/Clinical Labs MED
Vaccine and immunization coverage. regulation, reimbursement, R&D and related issues
Foreign entity interest: Sanofi SA
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.